Announcements Trials

Browse Landscape

Status

Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Oxaliplatin 21 pembrolizumab 17 Capecitabine 15 Nivolumab 13 Paclitaxel 12 Fluorouracil 12 Leucovorin 11 Docetaxel 10 atezolizumab 7 Trastuzumab 7 tislelizumab 5 Ramucirumab 5 durvalumab 4 Standard of Care 4 Magnetic Resonance Spectroscopy 4 Irinotecan 4 Cisplatin 4 Carboplatin 4 zolbetuximab 3 zimberelimab 3 apatinib 3 Specimen Handling 3 S 1 (combination) 3 Gemcitabine 3 Bevacizumab 3 trifluridine tipiracil drug combination 2 tremelimumab 2 trastuzumab deruxtecan 2 relatlimab 2 osimertinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Stomach Neoplasms × Methylene Blue × Clear all

NCT07147452 2025-08-29

SLN_GC_SPIO

Hospital del SAS de Jerez

Active not recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡